Ojibwe-Focused diabetes program aims to help families manage together

NCT ID NCT04734015

Completed Disease control Sponsor: Johns Hopkins Bloomberg School of Public Health Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a culturally tailored program called Together Overcoming Diabetes (TOD) for American Indian families in Ojibwe communities. Adult caregivers with type 2 diabetes and their youth (ages 10-16) worked with local health coaches to set health goals. The program included 14 lessons delivered at home over 6 months, focusing on spiritual, mental, physical, and emotional wellness. Researchers tracked changes in blood sugar, weight, and other health measures for up to 2 years.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Together Overcoming Diabetes (TOD) program
What this could lead to: If it works, this could offer a culturally respectful way to help American Indian families better manage type 2 diabetes and prevent it in younger generations.
What could go wrong: This is a completed behavioral study with 162 participants, so results may not apply to all communities. The program is intensive (14 lessons over 6 months) and may be hard to sustain long-term.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diabetes mellitus type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TYPE 2 DIABETES

Contacts and locations

Locations

Johns Hopkins University Great Lakes Hub

Duluth, Minnesota, 55812, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.